Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3013% below fair value
$2.01−0.06 (-2.66%)
Close on Nov 16, 2026Market cap $159.04MP/E 16.8Yield –
Niagen Bioscience operating margin
Operating margin is operating income as a percentage of revenue.
Niagen Bioscience's operating margin for the twelve months ending Sep 30, 2026 was 3.9%. For fiscal 2025 it was 12.6%, against 7.8% the year before. The highest annual figure on record is 12.6% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.6% | +4.8 |
| FY2024 | Dec 31, 2024 | 7.8% | +14.5 |
| FY2023 | Dec 31, 2023 | -6.7% | +19.2 |
| FY2022 | Dec 31, 2022 | -25.9% | +14.3 |
| FY2021 | Dec 31, 2021 | -40.1% | −6.6 |
| FY2020 | Dec 31, 2020 | -33.5% | +34.1 |
| FY2019 | Dec 31, 2019 | -67.6% | +37.5 |
| FY2018 | Dec 31, 2018 | -105.1% | −27.9 |
| FY2017 | Dec 30, 2017 | -77.2% | −63.8 |
| FY2016 | Dec 31, 2016 | -13.4% | −1.9 |
| FY2015 | Jan 2, 2016 | -11.6% | +22.6 |
| FY2014 | Jan 3, 2015 | -34.2% | +9.0 |
| FY2013 | Dec 28, 2013 | -43.2% | +57.1 |
| FY2012 | Dec 29, 2012 | -100.2% | −3.3 |
| FY2011 | Dec 31, 2011 | -96.9% | −70.3 |
| FY2010 | Jan 1, 2011 | -26.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -5.8% | −18.3 |
| Q2 FY2026 | Jun 30, 2026 | 2.4% | −7.9 |
| Q1 FY2026 | Mar 31, 2026 | 5.0% | −10.6 |
| Q4 FY2025 | Dec 31, 2025 | 12.1% | −12.3 |
| Q3 FY2025 | Sep 30, 2025 | 12.5% | +6.2 |
| Q2 FY2025 | Jun 30, 2025 | 10.2% | +11.4 |
| Q1 FY2025 | Mar 31, 2025 | 15.7% | +19.0 |
| Q4 FY2024 | Dec 31, 2024 | 24.4% | +25.2 |
| Q3 FY2024 | Sep 30, 2024 | 6.3% | +12.1 |
| Q2 FY2024 | Jun 30, 2024 | -1.1% | +10.3 |
| Q1 FY2024 | Mar 31, 2024 | -3.3% | +5.4 |
| Q4 FY2023 | Dec 31, 2023 | -0.8% | +6.1 |
| Q3 FY2023 | Sep 30, 2023 | -5.9% | +12.1 |
| Q2 FY2023 | Jun 30, 2023 | -11.4% | +26.8 |
| Q1 FY2023 | Mar 31, 2023 | -8.7% | +36.1 |
| Q4 FY2022 | Dec 31, 2022 | -6.9% | +23.1 |
| Q3 FY2022 | Sep 30, 2022 | -18.0% | +33.1 |
| Q2 FY2022 | Jun 30, 2022 | -38.2% | −6.8 |
| Q1 FY2022 | Mar 31, 2022 | -44.8% | +5.3 |
| Q4 FY2021 | Dec 31, 2021 | -29.9% | +9.4 |
| Q3 FY2021 | Sep 30, 2021 | -51.1% | −21.5 |
| Q2 FY2021 | Jun 30, 2021 | -31.4% | −7.3 |
| Q1 FY2021 | Mar 31, 2021 | -50.1% | −9.1 |
| Q4 FY2020 | Dec 31, 2020 | -39.4% | +28.3 |
| Q3 FY2020 | Sep 30, 2020 | -29.6% | +27.6 |
| Q2 FY2020 | Jun 30, 2020 | -24.1% | +40.6 |
| Q1 FY2020 | Mar 31, 2020 | -41.1% | +42.3 |
| Q4 FY2019 | Dec 31, 2019 | -67.7% | +23.2 |
| Q3 FY2019 | Sep 30, 2019 | -57.1% | +48.7 |
| Q2 FY2019 | Jun 30, 2019 | -64.7% | +37.0 |
| Q1 FY2019 | Mar 31, 2019 | -83.3% | +44.6 |
| Q4 FY2018 | Dec 31, 2018 | -90.9% | +25.7 |
| Q3 FY2018 | Sep 30, 2018 | -105.9% | −53.7 |
| Q2 FY2018 | Jun 30, 2018 | -101.7% | −52.9 |
| Q1 FY2018 | Mar 31, 2018 | -127.9% | −104.4 |
| Q4 FY2017 | Dec 30, 2017 | -116.6% | – |
| Q3 FY2017 | Sep 30, 2017 | -52.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -48.8% | – |
| Q3 FY2016 | Oct 1, 2016 | -23.5% | – |
See a number that looks wrong?